Background: Very preterm birth (<32 weeks gestation) is associated with an increased risk of developmental language disorder. Early language exposure is positively correlated with language skills with mean language exposure in typical development from age 2 to 48 months estimated at 12000 adult words per day. This pilot study compared the early language exposure of infants born very preterm (non-ventilated and stable) and well full-term born infants at term-equivalent age.
Background: Very preterm birth (<32 weeks gestation) is associated with an increased risk of developmental language disorder. Early language exposure is positively correlated with language skills with mean language exposure in typical development from age 2 to 48 months estimated at 12000 adult words per day. This pilot study compared the early language exposure of infants born very preterm (non-ventilated and stable) and well full-term born infants at term-equivalent age.
Methods: Very preterm (n = 11) and full-term infants (n = 10) were recruited and recorded with a Language ENvironmental Analysis (LENA) recording device in hospital at term equivalent age for 16 h. The LENA system provided a count of meaningful adult word exposure for each infant (adult word count).
Results: There was a significant difference between mean adult word count for the two groups (p = 0.02) with mean adult word count at 12367 and 5897 for the full-term and very preterm groups, respectively.
Conclusions: Very preterm infants receive less language exposure in the hospital environment than their full-term peers who are exposed to levels of adult language similar to previous estimates. This deficit in language exposure may contribute to poorer language outcomes in the preterm population. Background and Objective: The cellular mechanisms behind the vulnerability of males born prematurely is poorly understood. We recapitulate male vulnerability to white matter injury (WMI) in our mouse model of encephalopathy of the premature infant; we have investigated the source of these differences.
CONTRIBUTION OF DIFFERING INFLAMMATORY AND
Methods and Results: Postnatal day (P)1-P5 mice were administered interleukin-1β i.p. (Favrais et al., 2011) to set up a systemic inflammatory cascade driving neuroinflammation (NI), like that which contributes to WMI in preterm born infants. NI females had significantly higher levels of systemic inflammatory responses via luminex. Microglial cell number (Iba1+ cells) and microglial phenotype markers (7/9 genes) responded the same in males and females exposed to NI, but there was an interaction between sex and NI for IGF-1 (higher in females). The effect of NI on oligo number (Olig2 & APC) was not different by sex but gene expression for maturation markers was only dysregulated in males. However, female sex itself was significantly associated with higher numbers of total and mature oligos. At P1-P3, white matter cell death (cleaved caspase-3 cell number) was not increased by exposure to NI in either sex, but cell death was intrinsically lower in females. Microarray analysis of O4 expressing oligos at P10 revealed that specific to females was increased expression of multiple inflammatory pathways and genes in cell cycle and calcium signalling pathways only in males.
Conclusion: This data indicates multiple levels of sex differences. A comparison of the gene expression profile of male and female microglia will also be undertaken. Background: Postpartum haemorrhage (PPH) is a leading cause of maternal morbidity including need for blood transfusion. Maternal country of birth is a PPH risk factor. The Victorian Perinatal Data Collection (VPDC) collects data for each birth in Victoria and since 2009, PPH has been derived from reported estimated blood loss (EBL).
MATERNAL COUNTRY OF BIRTH AND BLOOD
Aim: To report the incidence of blood transfusion in women who had a ≥ 500 mL PPH by maternal country of birth for confinements in the VPDC for 2009-13.
Methods: Population-based retrospective cross-sectional study on VPDC data for eligible confinements (n = 78 629) for 2009-13. Cases with missing data were excluded. EBL was categorised as PPH ≥500 mL. Country of birth was coded into 10 geographic regions. Descriptive analysis was undertaken.
Results: 1.4% of all women and 5.6% of women who had a PPH received a blood transfusion. 5.9% of Australian-born who had a PPH had a transfusion. Women born in Europe and SubSaharan Africa were least likely (<5.0%) whereas South East (6.9%) and North East (6.2%) Asian-born women were most likely to receive a PPH-associated blood transfusion. For women born in Oceania the incidence of transfusion was 5.9% and 5.2-5.5% for women born in North Africa, the Middle East, Southern and Central Asia and the Americas.
Conclusions: These findings have important implications for women born in North East and South East Asia and Oceania. Reasons for higher incidence of transfusion in these groups and ways to prevent PPH and safely reduce the number of transfusions given need to be investigated.
